SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Maul Coin

Maul Coin is generating intense community buzz as supporters actively push for a chart listing while promoting it as an organic, developer-backed alternative to typical pump-and-dump schemes. Enthusiasts are rallying behind the project's growth, frequently comparing it to other meme tokens and encouraging others to hold for long-term gains.

Zebec's integrated products - real time payroll apps, on-chain payments infrastructure and networked DePIN - serve companies of all sizes, merchants and individuals and help transcend the boundaries of traditional banking and diminish the role of financial intermediaries.

Zebec Network

Zebec Network is trending as community members closely watch for an upcoming major partnership announcement, with many speculating it could involve Ripple or other financial infrastructure giants ahead of key industry events. Investors are actively debating the token's long-term utility in real-time payroll and streaming payments while closely monitoring technical price action and accumulation strategies.

QuickLogic Corp. operates as a semiconductor company, which designs, markets, and supports primarily Customer Specific Standard Products and secondarily, Field Programmable Gate Arrays, sensor software algorithms, software drivers, associated design software and programming hardware. It develops and markets low power customizable semiconductor and software algorithm solutions that enable customers to differentiate their products by adding new features, extending battery life, becoming more contextually aware and improving the visual experience with their mobile, consumer and enterprise products. The company was founded by John M. Birkner, Andrew K. Chan, and Hua-Thye Chua in 1988 and is headquartered in San Jose, CA.

Quicklogic Corp

QuickLogic is generating significant investor interest driven by its strategic partnership with Intel Foundry and its exclusive position as a provider of embedded FPGA (eFPGA) IP for the high-performance Intel 18A process node. The community is actively discussing the company's potential to become a critical supplier for defense and aerospace programs as the sector shifts toward domestic, radiation-hardened semiconductor solutions, with many highlighting the stock as a long-term play on edge AI and chiplet technology.

Algorand is a scalable, secure, and decentralized digital currency and smart contract platform. Its protocol uses a variation of Proof-of-Stake (PoS) called Pure PoS (PPoS) to secure the network and reach consensus on block production. Developers can build decentralized applications (dApps) using familiar programming languages, including Python, which Algorand supports natively. Its infrastructure enables various use cases, including payment systems, digital identity solutions, supply-chain tracking, and financial services. The protocol's architecture allows for tokenization of assets and the development of smart contracts, while its technical specifications support both retail users seeking basic transaction capabilities and enterprises requiring more, complex, blockchain solutions.

Algorand

Algorand is seeing increased market activity as traders react to positive signals in the broader altcoin sector and renewed institutional interest, leading to significant social media buzz. Community discussions are heavily focused on the project's long-term potential, its quantum-resistant technology, and a general optimistic sentiment surrounding its future role in finance.

Bitcoin Cash is a hard fork of Bitcoin with a protocol upgrade to fix on-chain capacity. Bitcoin Cash intends to be a Bitcoin without Segregated Witness (SegWit) as soft fork, where upgrades of the protocol are done mainly through hard forks and without changing the original economic rules of the Bitcoin.  Bitcoin Cash (BCH) is released on 1st August 2017 as an upgraded version of the original Bitcoin Core software. The main upgrade is the increase in the block size limit from 1MB to 8MB. This effectively allows miners on the BCH chain to process up to 8 times more payments per second in comparison to Bitcoin. This makes for faster, cheaper transactions and a much smoother user experience.  Why was Bitcoin Cash Created?  The main objective of Bitcoin Cash is to to bring back the essential qualities of money inherent in the original Bitcoin software. Over the years, these qualities were filtered out of Bitcoin Core and progress was stifled by various people, organizations, and companies involved in Bitcoin protocol development. The result is that Bitcoin Core is currently unusable as money due to increasingly high fees per transactions and transfer times taking hours to complete. This is all because of the 1MB limitation of Bitcoin Core’s block size, causing it unable to accommodate to large number of transactions.  Essentially Bitcoin Cash is a community-activated upgrade (otherwise known as a hard fork) of Bitcoin that increased the block size to 8MB, solving the scaling issues that plague Bitcoin Core today.  Nov 16th 2018: A hashwar resulted in a split between Bitcoin SV and Bitcoin ABC

Bitcoin Cash

Bitcoin Cash is capturing investor interest as the community highlights its upcoming technical upgrades and potential for decoupling from Bitcoin's price action. Market participants are actively debating its long-term viability as a peer-to-peer payment network while monitoring for bullish breakout signals.

PIMCO Dynamic Income Fund is a non-diversified, closed-end management investment company. Its seeks current income as a primary objective and capital appreciation as a secondary objective. The company was founded on January 19, 2011 and is headquartered in New York, NY.

PIMCO Dynamic Income Fund

PIMCO Dynamic Income Fund is seeing high community engagement as investors debate the impact of potential interest rate cuts on bond-heavy portfolios. While some participants are wary of recent institutional outflows and fund premiums, many long-term holders are actively utilizing discounted dividend reinvestment plans to accumulate shares during price fluctuations.

NeurAxis, Inc. engages in the provision of neuromodulation therapies to address chronic and debilitating conditions in children. Its product, IB-Stim, is a non-surgical device that works by sending gentle electrical impulses into cranial nerve bundles located in the ear. The company was founded by Gary Peterson and Christopher Robin Brown in 2011 and is headquartered in Carmel, IN.

Neuraxis Inc

NeurAxis is trending as investors react to its recent FDA clearance for its pediatric therapy, with the community actively debating whether the company will launch a stock offering or if the price action reflects a potential short squeeze. Traders are focused on the stock's low float and the long-term potential for institutional revenue growth as the company navigates its commercial rollout.

Suburban Propane Partners LP engages in the marketing and distribution of propane, renewable propane, fuel oil, and refined fuels. It operates through the following segments: Propane, Fuel Oil and Refined Fuels, Natural Gas and Electricity, and All Other. The Propane segment is involved in the retail distribution of propane to residential, commercial, industrial, agricultural, and government customers. The Fuel Oil and Refined Fuels segment supplies fuel oil, diesel, kerosene, and gasoline. The Natural Gas and Electricity segment focuses on marketing natural gas and electricity to residential and commercial customers. The All Other segment offers installation and servicing of a wide variety of home comfort equipment, particularly in the areas of heating and ventilation. The company was founded by Mark Anton in 1928 and is headquartered in Whippany, NJ.

Suburban Propane Partners LP - Unit

Suburban Propane Partners LP

Suburban Propane Partners is under scrutiny as investors debate the sustainability of its dividend yield against a backdrop of long-term stock underperformance and shifting energy market dynamics. While some traders are focused on technical breakouts and potential growth in renewable energy segments like hydrogen and RNG, others remain skeptical, citing concerns over management performance and historical stock volatility.

Avalo Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the treatment of immune dysregulation by developing therapies that target the LIGHT-signaling network. It also focuses on reducing LIGHT levels which can moderate immune dysregulation in many acute and chronic inflammatory disorders. The company was founded by Blake M. Paterson, Isaac Blech, Barbara S. Slusher, and Solomon H. Snyder on January 31, 2011 and is headquartered in Wayne, PA.

Avalo Therapeutics Inc

Avalo Therapeutics is attracting significant attention as investors monitor the progress of its lead Phase 2 candidate, AVTX-009, in treating hidradenitis suppurativa. The community remains focused on high trading volume, potential catalysts from trial data, and bullish analyst sentiment, while debating the firm's long-term financial stability and clinical execution.

McKesson Corp. engages in providing healthcare services. It operates through the following segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs. The RxTS segment offers prescription price transparency, benefit insight, dispensing support services, third-party logistics, and wholesale distribution. The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers. The International segment refers to the distribution and services to wholesale, institutional, and retail customers in Europe and Canada. The company was founded by John McKesson and Charles Olcott in 1833 and is headquartered in Irving, TX.

Mckesson Corporation

McKesson continues to capture investor interest as a resilient leader in pharmaceutical distribution, consistently hitting new all-time highs while drawing attention for its aggressive share buybacks, dividend increases, and strategic pivot toward oncology and specialty biopharma services. Market participants are actively tracking the stock's stability during broader market volatility, with many highlighting its role as a defensive holding that benefits from steady healthcare demand and ongoing operational efficiency gains.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$NULV
https://wallstreetwaves.com/significant-withdrawals-observed-in-nulv-etf/

The NULV ETF (Symbol: NULV) has experienced a significant outflow of approximately $216 million, representing an 11.3% decrease in shares outstanding from 46,550,000 to 41,300,000 week-over-week. Currently, NULV's share price stands at $41.19, within a 52-week range of $35.41 to $43.39.